Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 27.820% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a.) CC(C)(C)c1ccc(C(=O)NNc2ncccc2-n2cccc2)cc1
b.) COc1ccc(/C=C/c2nc(S(=O)(=O)c3ccccc3)c(N(C)C)o2)cc1
c.) N#CC1=C(N)Oc2nc(-c3ccccc3)[nH]c2C1c1cccnc1
d.) CCc1nn(CC(=O)NCCCN(CC)CC)c(=O)c2cc3sc(C)cc3n12
e.) Cl.O=C(CSc1nc(O)cc(=O)n1-c1ccccc1)Nc1ccccn1
Answer: e. Cl.O=C(CSc1nc(O)cc(=O)n1-c1ccccc1)Nc1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cl.O=C(CSc1nc(O)cc(=O)n1-c1ccccc1)Nc1ccccn1
Cl.O=C(CSc1nc(O)cc(=O)n1-c1ccccc1)Nc1ccccn1
2-(4-hydroxy-6-oxo-1-phenylpyrimidin-2-yl)sulfanyl-N-pyridin-2-ylacetamide;hydrochloride